Benjamin Liu

Appearances

GLUCAGON-LIKE PROTEIN-1 RECEPTOR AGONISTS ARE ASSOCIATED WITH AN INCREASED RISK OF DEVELOPING CHOLECYSTITIS BUT NOT ACUTE OR CHRONIC PANCREATITIS: RESULTS FROM A GLOBAL HEALTHCARE DATABASE
Date
May 7, 2023
It is controversial whether glucagon-like peptide 1 (GLP-1) receptor agonists (RA) are associated with adverse pancreatic, gallbladder or biliary outcomes…
Presenter
Benjamin Liu
Speakers
Samantha Mathialagan
Katherine Liang
Yasir Tarabichi
Gengqing Song
RE-EXAMINING THE RISKS OF GASTROINTESTINAL ADVERSE EVENTS ASSOCIATED WITH GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS FOR WEIGHT LOSS WITH MORE STRINGENT CRITERIA ON A COMPREHENSIVE LARGE DATABASE.
Date
May 21, 2024
Sodhi et al. (2023) recently reported that glucagon-like peptide-1 receptor agonists (GLP-1 RA) usage for weight loss was associated with increased risks of pancreatitis, gastroparesis, and bowel obstruction but not biliary disease when compared to bupropion-naltrexone (BN)…
Presenter
Benjamin Liu
Speaker
Gengqing Song